Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 278 000 KRW -1.07% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hanmi Pharm Co Ltd?
Write Note

Hanmi Pharm Co Ltd
Treasury Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hanmi Pharm Co Ltd
Treasury Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Treasury Stock CAGR 3Y CAGR 5Y CAGR 10Y
Hanmi Pharm Co Ltd
KRX:128940
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Treasury Stock
-â‚©14.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
3%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Treasury Stock
-â‚©568.1m
CAGR 3-Years
34%
CAGR 5-Years
22%
CAGR 10-Years
12%
C
Celltrion Pharm Inc
KOSDAQ:068760
Treasury Stock
-â‚©21.4B
CAGR 3-Years
-41%
CAGR 5-Years
-77%
CAGR 10-Years
-108%
No Stocks Found

Hanmi Pharm Co Ltd
Glance View

Market Cap
3.5T KRW
Industry
Pharmaceuticals

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2010-07-30. The firm operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.

Intrinsic Value
379 659.54 KRW
Undervaluation 27%
Intrinsic Value
Price

See Also

Back to Top